For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

Biomarkers to predict the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer with actionable genetic alterations. This is an ASCO Meeting Abstract from the 2023 ASCO ...

The recent emergence of bacterial infections that are resistant to many existing antibiotics is driving an urgent need for tools to quickly identify the small number of therapies that are still ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

Antimicrobial susceptibility testing is a laboratory procedure that is primarily used to determine whether antimicrobial drugs have an inhibitory effect on pathogenic microorganisms in vitro. It can ...

In recent years, many efforts have been undertaken to establish new methods for DST to be used on a routine level. The epidemiology of drug-resistant and MDR-TB has posed an enormous need for faster ...